News
In a Phase 1 clinical study, researchers led by EPFL and their partners report that a new liver- and gut-targeted oral drug can safely lower triglycerides and other blood lipids.
How do our institutions and the trust they are built on evolve in a digital world? Interview of Imad Aad, project manager at the Center for Digital Trust (C4DT) at EPFL.
When a miracle technology becomes a burden
Published:12.01.26 — Plastic is everywhere in modern society. While it has paved the way for enormous progress, the pollution it leaves behind is now creating major challenges.
Cracking the code for prostate cancer
Published:07.01.26 — Scientists at EPFL and Johns Hopkins uncover the central role of an enzyme in controlling prostate cancer subtypes and improving therapeutic response.
Safer receipt paper from wood
Published:05.01.26 — EPFL researchers have developed formulations for the kind of paper used in cash receipts or shipping tags using wood-based chemicals that reduces reliance on toxic bisphenols while keeping print performance.
2025: A year dominated by AI
Published:22.12.25 — What made EPFL shine over the past year? Its around 18,000 students and staff members. And what the media and internet users reported. Our 2025 Top 10.
How cells balance their protein levels
Published:23.12.25 — EPFL researchers have discovered how cells help keep their protein levels steady even when their ability to make new proteins changes. The finding could shed light on how our bodies stay resilient when nutrients and other resources rise and fall.
Are you sure you want to import this news into ?
This news will be sent to its subscribers.
